| Financial Year |
March 31 2023 |
| Monetary Funds |
179,548,221.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
48,635,443.01 |
| Accounts Receivable |
812,219,485.90 |
| Advances to Suppliers |
15,775,680.59 |
| Other Receivables |
20,350,953.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
437,433,374.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,206,017.35 |
| Total Current Assets |
1,576,634,717.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
94,876,141.58 |
| Investment Properties |
29,119,403.70 |
| Fixed Assetes |
306,249,717.34 |
| Under-construction Projects |
372,898,820.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
133,474,773.61 |
| R&D expenses |
-- |
| Goodwill |
82,377,862.75 |
| Long-Term Deferred and Prepaid Expenses |
7,451,033.20 |
| Deferred Income Tax Assets |
18,559,814.67 |
| Other Non-Current Assets |
8,570,009.29 |
| Sub-Total of Non-Current Assets |
1,260,621,105.02 |
| Total Assets |
2,837,255,822.02 |
| Short-Term Loans |
540,096,833.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
144,072,200.00 |
| Accounts Payable |
275,748,075.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,312,574.95 |
| Taxes Payable |
25,989,191.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,196,704.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,490,675.25 |
| Other Current Liabilities |
44,832,156.36 |
| Sub-Total of Current Liabilities |
1,132,855,357.48 |
| Long-term Loans |
254,925,589.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,259,565.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
472,317,553.99 |
| Total Liabilities |
1,605,172,911.47 |
| Paid-In Capital(Or Share Stock) |
193,064,916.00 |
| Capital Surplus |
674,285,183.11 |
| Surplus Reserve |
56,827,048.58 |
| LESS:Treasury Stock |
44,783,088.00 |
| Undistributed Profits |
351,048,167.44 |
| Minority Stockholder's Interest |
19,135.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,232,063,774.83 |
| Owner's Equity（Stockholder's Equity） |
1,232,082,910.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,837,255,822.02 |
